MATERIAL EVENT4569.TTSE

Kyorin Pharmaceutical: change in parent company or specified subsidiary

Summary

KYORIN Pharmaceutical Co., Ltd. filed an extraordinary report via EDINET on 2026-09-30 16:05 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100Z4JU ↗ · PDL1.0 · Not investment advice